Monthly
US$200
Billed every month
Sign in to subscribeDapagliflozin Tablets
As of 13 November 2026, for Dapagliflozin Tablets, 84 applications are listed as under review at China's CDE; 28 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 50 holders.
Companies, stages and changes, with each record available on this page.
Listed in the US FDA Orange Book as FARXIGA (NDA 202293, ASTRAZENECA AB).
Last 90 days: Marketing application approved: 4 applicationsAccepted: 17 applicationsTrial registration: 5 applicationsNo longer listed under review: 2 applications
Current coverage may be incomplete
US Orange Book listing
The brand names come from the US FDA Orange Book and describe US listing records for this active ingredient. They do not indicate that products under these brand names are approved or sold in China, or that Chinese applicants are affiliated with US holders.
Orange Book source export date: 2026/11/06. Version: 2026-11-06.
Showing 1 of 1 distinct brand names.
A brand with different source forms or statuses can appear on multiple rows and in both groups. Distinct brand names are counted once globally, with a limit of five.
Verified official English dosage form: Tablets. Listings are grouped by the source dosage form and route; records without a clear correspondence are listed in the other group. Grouping does not establish product equivalence.
Same dosage form
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| FARXIGA | ASTRAZENECA AB | NDA 202293 · Product no. 001, 002 | TABLET | ORAL | HUMAN PRESCRIPTION DRUG | 2014/01/08 |
Other dosage forms of the same ingredient
No listings in this group among the displayed brand names.
Same-form/route listings come first, followed by other forms/routes. Within each group, source prescription/OTC listings precede discontinued listings; unknown statuses are last. Each status bucket is ordered by earliest approval date, ascending: pre-1982 records first, missing dates last; ties by brand name, application number and product number. The first five distinct brands in this order are selected globally. All retained source facts for those brands are shown in their own groups; a brand spanning both groups counts once.
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders50View records ↓
Under-review filings84View records ↓
This year’s generic filers28View records ↓
NHSA approval numbers62View records ↓
API companies with A status40View records ↓
Chemical-drug catalogue
Loaded records: 50 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 49 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Hefei He Yuan Pharma Co., Ltd. romanized | Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20265802 | 2026/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei He Yuan Pharma Co., Ltd. romanized | Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20265803 | 2026/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Bei Ji Kang Pharmaceuticals Technology Co., Ltd. romanized | Jinan Gao Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20265824 | 2026/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Bei Ji Kang Pharmaceuticals Technology Co., Ltd. romanized | Jinan Gao Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20265825 | 2026/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized | Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized | 国药准字H20265732 | 2026/08/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized | Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized | 国药准字H20265731 | 2026/08/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | Jinan Gao Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20265670 | 2026/08/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | Jinan Gao Hua Pharmaceutical Co., Ltd. romanized | 国药准字H20265648 | 2026/08/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | Jiu Zhou Biopharmaceuticals (Tai Zhou) Co., Ltd. romanized | 国药准字H20265370 | 2026/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | Jiu Zhou Biopharmaceuticals (Tai Zhou) Co., Ltd. romanized | 国药准字H20265369 | 2026/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanghai Shyndec Pharmaceutical Co., Ltd. | Shanghai Shyndec Pharmaceutical Co., Ltd. | 国药准字H20265326 | 2026/07/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanghai Shyndec Pharmaceutical Co., Ltd. | Shanghai Shyndec Pharmaceutical Co., Ltd. | 国药准字H20265325 | 2026/07/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20265058 | 2026/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20265057 | 2026/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20269126 | 2026/05/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| ALEMBIC PHARMACEUTICALS LIMITED, FORMULATION DIVISION | ALEMBIC PHARMACEUTICALS LIMITED, FORMULATION DIVISION | 国药准字HJ20260050 | 2026/05/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| ALEMBIC PHARMACEUTICALS LIMITED, FORMULATION DIVISION | ALEMBIC PHARMACEUTICALS LIMITED, FORMULATION DIVISION | 国药准字HJ20260051 | 2026/05/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | 2026/04/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CISEN PHARMACEUTICAL CO., LTD. | CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | 2026/04/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | 2026/03/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | 2026/03/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | 2026/02/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | Topfond Pharmaceutical Co., Ltd. | 国药准字H20263290 | 2026/02/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | 2026/01/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | 2026/01/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263217 | 2026/01/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | 2026/01/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Bei Kang Pharmaceuticals Technology Co., Ltd. romanized | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20263177 | 2026/01/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Bei Kang Pharmaceuticals Technology Co., Ltd. romanized | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20263176 | 2026/01/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20256459 | 2025/12/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20256458 | 2025/12/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Kang Ke Er Pharmaceutical Co., Ltd. romanized | Chongqing Kang Ke Er Pharmaceutical Co., Ltd. romanized | 国药准字H20255773 | 2025/10/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Kang Ke Er Pharmaceutical Co., Ltd. romanized | Chongqing Kang Ke Er Pharmaceutical Co., Ltd. romanized | 国药准字H20255772 | 2025/10/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yue Kang Pharma Group Co., Ltd. romanized | Yue Kang Pharma Group Co., Ltd. romanized | 国药准字H20255613 | 2025/09/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20255293 | 2025/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| KRKA, d.d., Novo mesto | KRKA, d.d., Novo mesto | 国药准字HJ20250090 | 2025/07/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20254235 | 2025/05/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hui Sheng Biopharmaceutical Co., Ltd. romanized | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20253933 | 2025/04/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Henan Li Nuo Pharmaceutical Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20253905 | 2025/04/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hui Sheng Biopharmaceutical Co., Ltd. romanized | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20253934 | 2025/04/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Henan Li Nuo Pharmaceutical Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20253906 | 2025/04/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fu Yuan Pharma Co., Ltd. romanized | Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253764 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20253768 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20253767 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fu Yuan Pharma Co., Ltd. romanized | Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253782 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hetero Labs Limited | Hetero Labs Limited | 国药准字HJ20250030 | 2025/03/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hetero Labs Limited | Hetero Labs Limited | 国药准字HJ20250029 | 2025/03/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253316 | 2025/01/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253315 | 2025/01/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | Xin Hua Pharmaceutical (Gao Mi) Co., Ltd. romanized | 国药准字H20253304 | 2025/01/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Jiudian Pharmaceutical Co., Ltd | Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | 2024/12/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249659 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Hua Yi Pharmaceutical Co., Ltd. romanized | Zhejiang Hua Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20249541 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Hua Yi Pharmaceutical Co., Ltd. romanized | Zhejiang Hua Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20249540 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249660 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Wei Lin Heng Chang Pharmaceuticals Technology Co., Ltd. romanized | Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H20249285 | 2024/11/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Wei Lin Heng Chang Pharmaceuticals Technology Co., Ltd. romanized | Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H20249286 | 2024/11/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | 国药准字H20244736 | 2024/08/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244734 | 2024/08/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244735 | 2024/08/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | 国药准字H20244737 | 2024/08/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244369 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244370 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20244146 | 2024/06/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20244145 | 2024/06/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| M/s Cipla Ltd. | M/s Cipla Ltd. | 国药准字HJ20240025 | 2024/05/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20243380 | 2024/03/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20243381 | 2024/03/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20243086 | 2024/01/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20243087 | 2024/01/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Fang Sheng He Pharmaceuticals Technology Co., Ltd. romanized | Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20234636 | 2023/12/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| A Si Li Kang Pharma (Zhongguo) Co., Ltd. romanized | A Si Li Kang Pharma (Zhongguo) Co., Ltd. romanized | 国药准字H20234464 | 2023/11/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| A Si Li Kang Pharma (Zhongguo) Co., Ltd. romanized | A Si Li Kang Pharma (Zhongguo) Co., Ltd. romanized | 国药准字H20234463 | 2023/11/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20234191 | 2023/09/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | 国药准字H20233762 | 2023/06/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | 国药准字H20233761 | 2023/06/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing SL Pharmaceutical Co., Ltd. | Beijing SL Pharmaceutical Co., Ltd. | 国药准字H20233316 | 2023/03/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing SL Pharmaceutical Co., Ltd. | Beijing SL Pharmaceutical Co., Ltd. | 国药准字H20233315 | 2023/03/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | 2021/10/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Lukang Pharmaceutical Co.,Ltd. | Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213815 | 2021/10/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Lukang Pharmaceutical Co.,Ltd. | Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213816 | 2021/10/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| AstraZeneca AB | AstraZeneca Pharmaceuticals LP | H20170119;H20170120;H20170206 | 2017/03/10 | See source | Imported originator drug | CDE |
| AstraZeneca AB | AstraZeneca Pharmaceuticals LP | H20170117;H20170118;H20170205 | 2017/03/10 | See source | Imported originator drug | CDE |
| Suzhou Di Yi Pharmaceutical Co., Ltd. romanized | Suzhou Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20266379 | 2026/10/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Di Yi Pharmaceutical Co., Ltd. romanized | Suzhou Di Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20266380 | 2026/10/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized | Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20266274 | 2026/10/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized | Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20266275 | 2026/10/13 | See source | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 62 distinct approval numbers and 36 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010102753 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | See source | Category B | XA10BKD256A001010102877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010104127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263217 | See source | Category B | XA10BKD256A001010107011 | NHSA |
| Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20265802 | See source | Category B | XA10BKD256A001010109541 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265370 | See source | Category B | XA10BKD256A001010109637 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001010181767 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20263290 | See source | Category B | XA10BKD256A001010183846 | NHSA |
| Hainan Bei Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263176 | See source | Category B | XA10BKD256A001010185151 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010202753 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | See source | Category B | XA10BKD256A001010202877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010204127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263217 | See source | Category B | XA10BKD256A001010207011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265370 | See source | Category B | XA10BKD256A001010209637 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001010281767 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20263290 | See source | Category B | XA10BKD256A001010283846 | NHSA |
| Hainan Bei Kang Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20263176 | See source | Category B | XA10BKD256A001010285151 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010302753 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | See source | Category B | XA10BKD256A001010302877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010304127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263217 | See source | Category B | XA10BKD256A001010307011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265370 | See source | Category B | XA10BKD256A001010309637 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001010381767 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20263290 | See source | Category B | XA10BKD256A001010383846 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010402753 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | See source | Category B | XA10BKD256A001010402877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010404127 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265370 | See source | Category B | XA10BKD256A001010409637 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20263290 | See source | Category B | XA10BKD256A001010483846 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010502753 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | See source | Category B | XA10BKD256A001010502877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010504127 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265370 | See source | Category B | XA10BKD256A001010509637 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20263290 | See source | Category B | XA10BKD256A001010583846 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010602753 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | See source | Category B | XA10BKD256A001010602877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010604127 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265370 | See source | Category B | XA10BKD256A001010609637 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20263290 | See source | Category B | XA10BKD256A001010683846 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010702753 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | See source | Category B | XA10BKD256A001010702877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010704127 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265370 | See source | Category B | XA10BKD256A001010709637 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010802753 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263203 | See source | Category B | XA10BKD256A001010802877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010804127 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265370 | See source | Category B | XA10BKD256A001010809637 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001010902753 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001010904127 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20263477 | See source | Category B | XA10BKD256A001011002753 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001011004127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001011104127 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263950 | See source | Category B | XA10BKD256A001011204127 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | See source | Category B | XA10BKD256A001020102877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020104127 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20269126 | See source | Category B | XA10BKD256A001020104188 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020107011 | NHSA |
| Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20265803 | See source | Category B | XA10BKD256A001020109541 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265369 | See source | Category B | XA10BKD256A001020109637 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001020181767 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | See source | Category B | XA10BKD256A001020202877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020204127 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20269126 | See source | Category B | XA10BKD256A001020204188 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020207011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265369 | See source | Category B | XA10BKD256A001020209637 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001020281767 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | See source | Category B | XA10BKD256A001020302877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020304127 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20269126 | See source | Category B | XA10BKD256A001020304188 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020307011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265369 | See source | Category B | XA10BKD256A001020309637 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001020381767 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | See source | Category B | XA10BKD256A001020402877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020404127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020407011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265369 | See source | Category B | XA10BKD256A001020409637 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | See source | Category B | XA10BKD256A001020502877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020504127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020507011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265369 | See source | Category B | XA10BKD256A001020509637 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | See source | Category B | XA10BKD256A001020602877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020604127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020607011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265369 | See source | Category B | XA10BKD256A001020609637 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | See source | Category B | XA10BKD256A001020702877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020704127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020707011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265369 | See source | Category B | XA10BKD256A001020709637 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20263204 | See source | Category B | XA10BKD256A001020802877 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020804127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020807011 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001020904127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001020907011 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001021004127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021007011 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001021104127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021107011 | NHSA |
| CISEN PHARMACEUTICAL CO., LTD. | 国药准字H20263949 | See source | Category B | XA10BKD256A001021204127 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021207011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021307011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021407011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021507011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021607011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021707011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021807011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001021907011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022007011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022107011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022207011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022307011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022407011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022507011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022607011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022707011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001022807011 | NHSA |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | 国药准字H20263216 | See source | Category B | XA10BKD256A001030107011 | NHSA |
| Zhejiang Hong Yuan Pharma Co., Ltd. romanized | 国药准字H20265369 | See source | Category B | XA10BKD256A001030109637 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001030181767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001030281767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001030381767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001030481767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001030581767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001030681767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263619 | See source | Category B | XA10BKD256A001030781767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001040181767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001040281767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001040381767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001040481767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001040581767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001040681767 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20263620 | See source | Category B | XA10BKD256A001040781767 | NHSA |
| Beijing SL Pharmaceutical Co., Ltd. | 国药准字H20233315 | See source | Category B | XA10BKD256A001010100148 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | See source | Category B | XA10BKD256A001010100177 | NHSA |
| Yue Kang Pharma Group Co., Ltd. romanized | 国药准字H20255613 | See source | Category B | XA10BKD256A001010100239 | NHSA |
| AstraZeneca AB | 国药准字J20170040 | See source | Category B | XA10BKD256A001010101359 | NHSA |
| Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | 国药准字H20244736 | See source | Category B | XA10BKD256A001010101533 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20234196 | See source | Category B | XA10BKD256A001010101606 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244369 | See source | Category B | XA10BKD256A001010102763 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20243380 | See source | Category B | XA10BKD256A001010102770 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20244145 | See source | Category B | XA10BKD256A001010104565 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249659 | See source | Category B | XA10BKD256A001010104647 | NHSA |
| Zhejiang Hua Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20249540 | See source | Category B | XA10BKD256A001010104650 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010104942 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253315 | See source | Category B | XA10BKD256A001010106632 | NHSA |
| A Si Li Kang Pharma (Zhongguo) Co., Ltd. romanized | 国药准字H20234463 | See source | Category B | XA10BKD256A001010110153 | NHSA |
| AstraZeneca AB | 国药准字HJ20170119 | See source | Category B | XA10BKD256A001010179096 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | See source | Category B | XA10BKD256A001010179426 | NHSA |
| M/s Cipla Ltd. | 国药准字HJ20240025 | See source | Category B | XA10BKD256A001010179537 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20255293 | See source | Category B | XA10BKD256A001010180086 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253764 | See source | Category B | XA10BKD256A001010180651 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213815 | See source | Category B | XA10BKD256A001010183198 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249285 | See source | Category B | XA10BKD256A001010183203 | NHSA |
| Nanjing Fang Sheng He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234636 | See source | Category B | XA10BKD256A001010183343 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010183521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010183775 | NHSA |
| KRKA,d.d., Novo mesto | 国药准字HJ20250090 | See source | Category B | XA10BKD256A001010184240 | NHSA |
| Henan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253905 | See source | Category B | XA10BKD256A001010185024 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | See source | Category B | XA10BKD256A001010200177 | NHSA |
| Yue Kang Pharma Group Co., Ltd. romanized | 国药准字H20255613 | See source | Category B | XA10BKD256A001010200239 | NHSA |
| AstraZeneca AB | 国药准字J20170040 | See source | Category B | XA10BKD256A001010201359 | NHSA |
| Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | 国药准字H20233761 | See source | Category B | XA10BKD256A001010201444 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20243380 | See source | Category B | XA10BKD256A001010202770 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20244145 | See source | Category B | XA10BKD256A001010204565 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249659 | See source | Category B | XA10BKD256A001010204647 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010204942 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253315 | See source | Category B | XA10BKD256A001010206632 | NHSA |
| A Si Li Kang Pharma (Zhongguo) Co., Ltd. romanized | 国药准字H20234463 | See source | Category B | XA10BKD256A001010210153 | NHSA |
| AstraZeneca AB | 国药准字HJ20170119 | See source | Category B | XA10BKD256A001010279096 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | See source | Category B | XA10BKD256A001010279426 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20255293 | See source | Category B | XA10BKD256A001010280086 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253764 | See source | Category B | XA10BKD256A001010280651 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213815 | See source | Category B | XA10BKD256A001010283198 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249285 | See source | Category B | XA10BKD256A001010283203 | NHSA |
| Nanjing Fang Sheng He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234636 | See source | Category B | XA10BKD256A001010283343 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010283521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010283775 | NHSA |
| KRKA,d.d., Novo mesto | 国药准字HJ20250090 | See source | Category B | XA10BKD256A001010284240 | NHSA |
| Henan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253905 | See source | Category B | XA10BKD256A001010285024 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | See source | Category B | XA10BKD256A001010300177 | NHSA |
| AstraZeneca AB | 国药准字J20170040 | See source | Category B | XA10BKD256A001010301359 | NHSA |
| Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | 国药准字H20233761 | See source | Category B | XA10BKD256A001010301444 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249659 | See source | Category B | XA10BKD256A001010304647 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010304942 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253315 | See source | Category B | XA10BKD256A001010306632 | NHSA |
| AstraZeneca AB | 国药准字HJ20170120 | See source | Category B | XA10BKD256A001010379096 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | See source | Category B | XA10BKD256A001010379426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253764 | See source | Category B | XA10BKD256A001010380651 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213815 | See source | Category B | XA10BKD256A001010383198 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249285 | See source | Category B | XA10BKD256A001010383203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010383521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010383775 | NHSA |
| KRKA,d.d., Novo mesto | 国药准字HJ20250090 | See source | Category B | XA10BKD256A001010384240 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | See source | Category B | XA10BKD256A001010400177 | NHSA |
| Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | 国药准字H20233761 | See source | Category B | XA10BKD256A001010401444 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20254235 | See source | Category B | XA10BKD256A001010404188 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249659 | See source | Category B | XA10BKD256A001010404647 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010404942 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253315 | See source | Category B | XA10BKD256A001010406632 | NHSA |
| AstraZeneca AB | 国药准字HJ20170120 | See source | Category B | XA10BKD256A001010479096 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | See source | Category B | XA10BKD256A001010479426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253764 | See source | Category B | XA10BKD256A001010480651 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213815 | See source | Category B | XA10BKD256A001010483198 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249285 | See source | Category B | XA10BKD256A001010483203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010483521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010483775 | NHSA |
| KRKA,d.d., Novo mesto | 国药准字HJ20250090 | See source | Category B | XA10BKD256A001010484240 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | See source | Category B | XA10BKD256A001010500177 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20254235 | See source | Category B | XA10BKD256A001010504188 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010504942 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253315 | See source | Category B | XA10BKD256A001010506632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | See source | Category B | XA10BKD256A001010579426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253764 | See source | Category B | XA10BKD256A001010580651 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249285 | See source | Category B | XA10BKD256A001010583203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010583521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010583775 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | See source | Category B | XA10BKD256A001010600177 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20254235 | See source | Category B | XA10BKD256A001010604188 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010604942 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | See source | Category B | XA10BKD256A001010679426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253764 | See source | Category B | XA10BKD256A001010680651 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249285 | See source | Category B | XA10BKD256A001010683203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010683521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010683775 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | See source | Category B | XA10BKD256A001010700177 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010704942 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | See source | Category B | XA10BKD256A001010779426 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249285 | See source | Category B | XA10BKD256A001010783203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010783521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010783775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010804942 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250029 | See source | Category B | XA10BKD256A001010879426 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249285 | See source | Category B | XA10BKD256A001010883203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010883521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010883775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001010904942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001010983521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001010983775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011004942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011083521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011083775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011104942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011183521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011183775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011204942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011283521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011283775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011304942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011383521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011383775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011404942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011483521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011483775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011504942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011583521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011583775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011604942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011683521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011683775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011704942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011783521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011783775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011804942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011883521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011883775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001011904942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001011983521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001011983775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001012004942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012083521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001012083775 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20249826 | See source | Category B | XA10BKD256A001012104942 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012183521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001012183775 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012283521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001012283775 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012383521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001012383775 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012483521 | NHSA |
| Hebei Zhi Heng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253304 | See source | Category B | XA10BKD256A001012483775 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001012983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001013983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001014083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001014183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001014283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001014383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001014483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244367 | See source | Category B | XA10BKD256A001014583521 | NHSA |
| Beijing SL Pharmaceutical Co., Ltd. | 国药准字H20233316 | See source | Category B | XA10BKD256A001020100148 | NHSA |
| AstraZeneca AB | 国药准字J20170039 | See source | Category B | XA10BKD256A001020101359 | NHSA |
| Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | 国药准字H20244737 | See source | Category B | XA10BKD256A001020101533 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20234191 | See source | Category B | XA10BKD256A001020101606 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20244370 | See source | Category B | XA10BKD256A001020102763 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20243381 | See source | Category B | XA10BKD256A001020102770 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20244146 | See source | Category B | XA10BKD256A001020104565 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249660 | See source | Category B | XA10BKD256A001020104647 | NHSA |
| Zhejiang Hua Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20249541 | See source | Category B | XA10BKD256A001020104650 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253316 | See source | Category B | XA10BKD256A001020106632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | See source | Category B | XA10BKD256A001020179426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253782 | See source | Category B | XA10BKD256A001020180651 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213816 | See source | Category B | XA10BKD256A001020183198 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020183203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020183521 | NHSA |
| Henan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253906 | See source | Category B | XA10BKD256A001020185024 | NHSA |
| AstraZeneca AB | 国药准字J20170039 | See source | Category B | XA10BKD256A001020201359 | NHSA |
| Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | 国药准字H20233762 | See source | Category B | XA10BKD256A001020201444 | NHSA |
| Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | 国药准字H20244737 | See source | Category B | XA10BKD256A001020201533 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20243381 | See source | Category B | XA10BKD256A001020202770 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20244146 | See source | Category B | XA10BKD256A001020204565 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249660 | See source | Category B | XA10BKD256A001020204647 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253316 | See source | Category B | XA10BKD256A001020206632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | See source | Category B | XA10BKD256A001020279426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253782 | See source | Category B | XA10BKD256A001020280651 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213816 | See source | Category B | XA10BKD256A001020283198 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020283203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020283521 | NHSA |
| Henan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253906 | See source | Category B | XA10BKD256A001020285024 | NHSA |
| Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | 国药准字H20244737 | See source | Category B | XA10BKD256A001020301533 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249660 | See source | Category B | XA10BKD256A001020304647 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253316 | See source | Category B | XA10BKD256A001020306632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | See source | Category B | XA10BKD256A001020379426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253782 | See source | Category B | XA10BKD256A001020380651 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213816 | See source | Category B | XA10BKD256A001020383198 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020383203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020383521 | NHSA |
| Kun Shan Long Deng Rui Di Pharmaceutical Co., Ltd. romanized | 国药准字H20244737 | See source | Category B | XA10BKD256A001020401533 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249660 | See source | Category B | XA10BKD256A001020404647 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253316 | See source | Category B | XA10BKD256A001020406632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | See source | Category B | XA10BKD256A001020479426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253782 | See source | Category B | XA10BKD256A001020480651 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213816 | See source | Category B | XA10BKD256A001020483198 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020483203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020483521 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249660 | See source | Category B | XA10BKD256A001020504647 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253316 | See source | Category B | XA10BKD256A001020506632 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | See source | Category B | XA10BKD256A001020579426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253782 | See source | Category B | XA10BKD256A001020580651 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020583203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020583521 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20249660 | See source | Category B | XA10BKD256A001020604647 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | See source | Category B | XA10BKD256A001020679426 | NHSA |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H20253782 | See source | Category B | XA10BKD256A001020680651 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020683203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020683521 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | See source | Category B | XA10BKD256A001020779426 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020783203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020783521 | NHSA |
| Hetero Labs Limited | 国药准字HJ20250030 | See source | Category B | XA10BKD256A001020879426 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020883203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020883521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001020983203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001020983521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021083203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021083521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021183203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021183521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021283203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021283521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021383203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021383521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021483203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021483521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021583203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021583521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021683203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021683521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021783203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021783521 | NHSA |
| You Hui Pharma (Beijing) Co., Ltd. romanized | 国药准字H20249286 | See source | Category B | XA10BKD256A001021883203 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001021983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001022983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001023983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001024083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001024183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001024283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001024383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001024483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20244368 | See source | Category B | XA10BKD256A001024583521 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213815 | See source | Category B | XA10BKD256A001030183198 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213815 | See source | Category B | XA10BKD256A001030283198 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213815 | See source | Category B | XA10BKD256A001030383198 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213816 | See source | Category B | XA10BKD256A001040183198 | NHSA |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized | 国药准字H20263290 | See source | Category B | XA10BKD256A001010783846 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 84 filings and 48 distinct first applicants.
Supplement 6 · Generic 78
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hunan Jiudian Pharmaceutical Co., Ltd | CYHB2601896 | Supplement | 2026/10/15 | Not stated by source | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHS2602530 | Generic | 2026/10/14 | Not stated by source | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHS2602529 | Generic | 2026/10/14 | Not stated by source | CDE |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Yan Tai Dong Cheng Da Yang Pharmaceutical Co., Ltd. romanized | CYHS2602379 | Generic | 2026/09/22 | Not stated by source | CDE |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Yan Tai Dong Cheng Da Yang Pharmaceutical Co., Ltd. romanized | CYHS2602378 | Generic | 2026/09/22 | Not stated by source | CDE |
| Zhao Yang Long Cheng Pharmaceutical Co., Ltd. romanized | CYHS2602295 | Generic | 2026/09/16 | Not stated by source | CDE |
| Zhao Yang Long Cheng Pharmaceutical Co., Ltd. romanized | CYHS2602294 | Generic | 2026/09/16 | Not stated by source | CDE |
| Shandong Lukang Pharmaceutical Co.,Ltd. | CYHB2601679 | Supplement | 2026/09/03 | Not stated by source | CDE |
| Shandong Lukang Pharmaceutical Co.,Ltd. | CYHB2601678 | Supplement | 2026/09/03 | Not stated by source | CDE |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | CYHS2602153 | Generic | 2026/08/28 | Not stated by source | CDE |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | CYHS2602152 | Generic | 2026/08/28 | Not stated by source | CDE |
| Tai Kang Hai En Pharma Co., Ltd. romanized | CYHS2602126 | Generic | 2026/08/26 | Not stated by source | CDE |
| Tai Kang Hai En Pharma Co., Ltd. romanized | CYHS2602125 | Generic | 2026/08/26 | Not stated by source | CDE |
| YaoPharma Co., Ltd. | CYHS2602007 | Generic | 2026/08/13 | Not stated by source | CDE |
| YaoPharma Co., Ltd. | CYHS2602006 | Generic | 2026/08/13 | Not stated by source | CDE |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | CYHS2601938 | Generic | 2026/08/10 | Not stated by source | CDE |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | CYHS2601937 | Generic | 2026/08/10 | Not stated by source | CDE |
| Hubei Sheng Hong Yuan Pharma Technology Co., Ltd. romanized; Hubei Tong De Tang Pharma Co., Ltd. romanized | CYHS2601897 | Generic | 2026/08/05 | Not stated by source | CDE |
| Hubei Sheng Hong Yuan Pharma Technology Co., Ltd. romanized; Hubei Tong De Tang Pharma Co., Ltd. romanized | CYHS2601896 | Generic | 2026/08/05 | Not stated by source | CDE |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | CYHS2601837 | Generic | 2026/07/30 | Not stated by source | CDE |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | CYHS2601836 | Generic | 2026/07/30 | Not stated by source | CDE |
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2601806 | Generic | 2026/07/28 | Not stated by source | CDE |
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2601805 | Generic | 2026/07/28 | Not stated by source | CDE |
| Beijing Sai Er Bio Pharma Co., Ltd. romanized | CYHS2601778 | Generic | 2026/07/24 | Not stated by source | CDE |
| Beijing Sai Er Bio Pharma Co., Ltd. romanized | CYHS2601777 | Generic | 2026/07/24 | Not stated by source | CDE |
| Hebei Wan Sui Pharma Co., Ltd. romanized | CYHS2601768 | Generic | 2026/07/23 | Not stated by source | CDE |
| Hebei Wan Sui Pharma Co., Ltd. romanized | CYHS2601767 | Generic | 2026/07/23 | Not stated by source | CDE |
| Ti Ke (Hubei) Pharmaceuticals Co., Ltd. romanized; Hubei Ji An Tang Pharma Co., Ltd. romanized | CYHS2601623 | Generic | 2026/07/08 | Not stated by source | CDE |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized; Yang Ling Bu Zhang Pharmaceutical Co., Ltd. romanized | CYHS2601446 | Generic | 2026/06/18 | Not stated by source | CDE |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized; Yang Ling Bu Zhang Pharmaceutical Co., Ltd. romanized | CYHS2601445 | Generic | 2026/06/18 | Not stated by source | CDE |
| Ren Xi Pharmaceuticals Technology Hebei Co., Ltd. romanized; Topfond Pharmaceutical Co., Ltd. | CYHB2601145 | Supplement | 2026/06/17 | Not stated by source | CDE |
| Di Sha Pharma Group Co., Ltd. romanized | CYHS2601369 | Generic | 2026/06/10 | Not stated by source | CDE |
| Yang Zi Jiang Pharma Group Shanghai Hai Ni Pharma Co., Ltd. romanized | CYHS2601300 | Generic | 2026/06/04 | Not stated by source | CDE |
| Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CYHS2601229 | Generic | 2026/06/01 | Not stated by source | CDE |
| Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CYHS2601228 | Generic | 2026/06/01 | Not stated by source | CDE |
| HAINAN HUALON PHARMACEUTICAL CO.,LTD | CYHS2601130 | Generic | 2026/05/14 | Not stated by source | CDE |
| HAINAN HUALON PHARMACEUTICAL CO.,LTD | CYHS2601126 | Generic | 2026/05/14 | Not stated by source | CDE |
| Le Tai Pharma Co., Ltd. romanized | CYHS2601056 | Generic | 2026/05/08 | Not stated by source | CDE |
| Le Tai Pharma Co., Ltd. romanized | CYHS2601055 | Generic | 2026/05/08 | Not stated by source | CDE |
| Hubei Guang Ji Pharma Co., Ltd. romanized | CYHS2600934 | Generic | 2026/04/23 | Not stated by source | CDE |
| Hubei Guang Ji Pharma Co., Ltd. romanized | CYHS2600933 | Generic | 2026/04/23 | Not stated by source | CDE |
| Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2600601 | Generic | 2026/03/02 | Not stated by source | CDE |
| Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2600600 | Generic | 2026/03/02 | Not stated by source | CDE |
| Shanghai Heng Shan Pharma Co., Ltd. romanized | CYHS2600365 | Generic | 2026/02/04 | Not stated by source | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | CYHS2600330 | Generic | 2026/01/31 | Not stated by source | CDE |
| Shandong Nuo He Kang Pharma Co., Ltd. romanized | CYHS2600265 | Generic | 2026/01/23 | Not stated by source | CDE |
| Shandong Nuo He Kang Pharma Co., Ltd. romanized | CYHS2600264 | Generic | 2026/01/23 | Not stated by source | CDE |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized; Liaoning Kang Bo Shi Pharmaceutical Co., Ltd. romanized | CYHS2600220 | Generic | 2026/01/20 | Not stated by source | CDE |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized; Liaoning Kang Bo Shi Pharmaceutical Co., Ltd. romanized | CYHS2600219 | Generic | 2026/01/20 | Not stated by source | CDE |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | CYHS2600211 | Generic | 2026/01/17 | Not stated by source | CDE |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | CYHS2600210 | Generic | 2026/01/17 | Not stated by source | CDE |
| Shandong Cheng Chuang Lan Hai Pharmaceuticals Technology Co., Ltd. romanized; Yuan Da Sheng Ming Ke Xue (Shandong) Co., Ltd. romanized | CYHS2600090 | Generic | 2026/01/08 | Not stated by source | CDE |
| Shandong Cheng Chuang Lan Hai Pharmaceuticals Technology Co., Ltd. romanized; Yuan Da Sheng Ming Ke Xue (Shandong) Co., Ltd. romanized | CYHS2600089 | Generic | 2026/01/08 | Not stated by source | CDE |
| Jiangsu Shen Hua Pharma Co., Ltd. romanized | CYHS2503762 | Generic | 2025/10/22 | Not stated by source | CDE |
| Jiangsu Ya Bang Ai Pu Sen Pharma Co., Ltd. romanized | CYHS2503980 | Generic | 2025/11/18 | Not stated by source | CDE |
| Jiangsu Ya Bang Ai Pu Sen Pharma Co., Ltd. romanized | CYHS2503979 | Generic | 2025/11/18 | Not stated by source | CDE |
| Jiangxi Pharmaceutical Co., Ltd. romanized | CYHS2602580 | Generic | 2026/10/21 | Not stated by source | CDE |
| Jiangxi Pharmaceutical Co., Ltd. romanized | CYHS2602579 | Generic | 2026/10/21 | Not stated by source | CDE |
| Shuang He Tian An Pharma (Guizhou) Co., Ltd. romanized | CYHS2504435 | Generic | 2025/12/26 | Not stated by source | CDE |
| Shuang He Tian An Pharma (Guizhou) Co., Ltd. romanized | CYHS2504434 | Generic | 2025/12/26 | Not stated by source | CDE |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | CYHS2504385 | Generic | 2025/12/25 | Not stated by source | CDE |
| Shandong Lu Ning Pharma Co., Ltd. romanized | CYHS2504366 | Generic | 2025/12/24 | Not stated by source | CDE |
| Shandong Lu Ning Pharma Co., Ltd. romanized | CYHS2504365 | Generic | 2025/12/24 | Not stated by source | CDE |
| Zhejiang Wei Kang Pharmaceutical Co., Ltd. romanized | CYHS2504189 | Generic | 2025/12/05 | Not stated by source | CDE |
| Zhejiang Wei Kang Pharmaceutical Co., Ltd. romanized | CYHS2504188 | Generic | 2025/12/05 | Not stated by source | CDE |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | CYHS2503891 | Generic | 2025/11/06 | Not stated by source | CDE |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | CYHS2503890 | Generic | 2025/11/06 | Not stated by source | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2503766 | Generic | 2025/10/22 | Not stated by source | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2503765 | Generic | 2025/10/22 | Not stated by source | CDE |
| Sichuan Yi Sheng Zhi Tong Pharmaceuticals Bio Technology Development Co., Ltd. romanized; Chongqing Bo Teng Pharma Co., Ltd. romanized | CYHS2503358 | Generic | 2025/09/10 | Not stated by source | CDE |
| Sichuan Yi Sheng Zhi Tong Pharmaceuticals Bio Technology Development Co., Ltd. romanized; Chongqing Bo Teng Pharma Co., Ltd. romanized | CYHS2503356 | Generic | 2025/09/10 | Not stated by source | CDE |
| Henan Pu Rui Pharma Co., Ltd. romanized | CYHS2503255 | Generic | 2025/09/04 | Not stated by source | CDE |
| Henan Pu Rui Pharma Co., Ltd. romanized | CYHS2503254 | Generic | 2025/09/04 | Not stated by source | CDE |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | CYHS2502956 | Generic | 2025/08/13 | Not stated by source | CDE |
| Gan Li Pharma Shandong Co., Ltd. romanized | CYHS2502790 | Generic | 2025/08/02 | Not stated by source | CDE |
| TIANJIN LISHENG PHARMACEUTICAL CO., LTD | CYHS2502658 | Generic | 2025/07/23 | Not stated by source | CDE |
| TIANJIN LISHENG PHARMACEUTICAL CO., LTD | CYHS2502657 | Generic | 2025/07/23 | Not stated by source | CDE |
| Zhejiang Qi Zheng Pharma Co., Ltd. romanized | CYHS2502418 | Generic | 2025/07/08 | Not stated by source | CDE |
| Zhejiang Qi Zheng Pharma Co., Ltd. romanized | CYHS2502417 | Generic | 2025/07/08 | Not stated by source | CDE |
| Topfond Pharmaceutical Co., Ltd. | CYHS2501871 | Generic | 2025/05/24 | Not stated by source | CDE |
| Topfond Pharmaceutical Co., Ltd. | CYHS2501870 | Generic | 2025/05/24 | Not stated by source | CDE |
| Sichuan Gowell Pharmaceutical Co., Ltd. | CYHS2102104 | Generic | 2021/11/30 | Not stated by source | CDE |
| Shandong Li Nuo Pharmaceutical Co., Ltd. romanized; Chongqing Bo Teng Pharma Co., Ltd. romanized | CYHB2602047 | Supplement | 2026/11/11 | Not stated by source | CDE |
| Shandong Li Nuo Pharmaceutical Co., Ltd. romanized; Chongqing Bo Teng Pharma Co., Ltd. romanized | CYHB2602046 | Supplement | 2026/11/11 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 51 filings and 28 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHS2602530 | Generic | 2026/10/14 | Not stated by source | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHS2602529 | Generic | 2026/10/14 | Not stated by source | CDE |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Yan Tai Dong Cheng Da Yang Pharmaceutical Co., Ltd. romanized | CYHS2602379 | Generic | 2026/09/22 | Not stated by source | CDE |
| Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Yan Tai Dong Cheng Da Yang Pharmaceutical Co., Ltd. romanized | CYHS2602378 | Generic | 2026/09/22 | Not stated by source | CDE |
| Zhao Yang Long Cheng Pharmaceutical Co., Ltd. romanized | CYHS2602295 | Generic | 2026/09/16 | Not stated by source | CDE |
| Zhao Yang Long Cheng Pharmaceutical Co., Ltd. romanized | CYHS2602294 | Generic | 2026/09/16 | Not stated by source | CDE |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | CYHS2602153 | Generic | 2026/08/28 | Not stated by source | CDE |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | CYHS2602152 | Generic | 2026/08/28 | Not stated by source | CDE |
| Tai Kang Hai En Pharma Co., Ltd. romanized | CYHS2602126 | Generic | 2026/08/26 | Not stated by source | CDE |
| Tai Kang Hai En Pharma Co., Ltd. romanized | CYHS2602125 | Generic | 2026/08/26 | Not stated by source | CDE |
| YaoPharma Co., Ltd. | CYHS2602007 | Generic | 2026/08/13 | Not stated by source | CDE |
| YaoPharma Co., Ltd. | CYHS2602006 | Generic | 2026/08/13 | Not stated by source | CDE |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | CYHS2601938 | Generic | 2026/08/10 | Not stated by source | CDE |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | CYHS2601937 | Generic | 2026/08/10 | Not stated by source | CDE |
| Hubei Sheng Hong Yuan Pharma Technology Co., Ltd. romanized; Hubei Tong De Tang Pharma Co., Ltd. romanized | CYHS2601897 | Generic | 2026/08/05 | Not stated by source | CDE |
| Hubei Sheng Hong Yuan Pharma Technology Co., Ltd. romanized; Hubei Tong De Tang Pharma Co., Ltd. romanized | CYHS2601896 | Generic | 2026/08/05 | Not stated by source | CDE |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | CYHS2601837 | Generic | 2026/07/30 | Not stated by source | CDE |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | CYHS2601836 | Generic | 2026/07/30 | Not stated by source | CDE |
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2601806 | Generic | 2026/07/28 | Not stated by source | CDE |
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2601805 | Generic | 2026/07/28 | Not stated by source | CDE |
| Beijing Sai Er Bio Pharma Co., Ltd. romanized | CYHS2601778 | Generic | 2026/07/24 | Not stated by source | CDE |
| Beijing Sai Er Bio Pharma Co., Ltd. romanized | CYHS2601777 | Generic | 2026/07/24 | Not stated by source | CDE |
| Hebei Wan Sui Pharma Co., Ltd. romanized | CYHS2601768 | Generic | 2026/07/23 | Not stated by source | CDE |
| Hebei Wan Sui Pharma Co., Ltd. romanized | CYHS2601767 | Generic | 2026/07/23 | Not stated by source | CDE |
| Ti Ke (Hubei) Pharmaceuticals Co., Ltd. romanized; Hubei Ji An Tang Pharma Co., Ltd. romanized | CYHS2601623 | Generic | 2026/07/08 | Not stated by source | CDE |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized; Yang Ling Bu Zhang Pharmaceutical Co., Ltd. romanized | CYHS2601446 | Generic | 2026/06/18 | Not stated by source | CDE |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized; Yang Ling Bu Zhang Pharmaceutical Co., Ltd. romanized | CYHS2601445 | Generic | 2026/06/18 | Not stated by source | CDE |
| Di Sha Pharma Group Co., Ltd. romanized | CYHS2601369 | Generic | 2026/06/10 | Not stated by source | CDE |
| Yang Zi Jiang Pharma Group Shanghai Hai Ni Pharma Co., Ltd. romanized | CYHS2601300 | Generic | 2026/06/04 | Not stated by source | CDE |
| Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CYHS2601229 | Generic | 2026/06/01 | Not stated by source | CDE |
| Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CYHS2601228 | Generic | 2026/06/01 | Not stated by source | CDE |
| HAINAN HUALON PHARMACEUTICAL CO.,LTD | CYHS2601130 | Generic | 2026/05/14 | Not stated by source | CDE |
| HAINAN HUALON PHARMACEUTICAL CO.,LTD | CYHS2601126 | Generic | 2026/05/14 | Not stated by source | CDE |
| Le Tai Pharma Co., Ltd. romanized | CYHS2601056 | Generic | 2026/05/08 | Not stated by source | CDE |
| Le Tai Pharma Co., Ltd. romanized | CYHS2601055 | Generic | 2026/05/08 | Not stated by source | CDE |
| Hubei Guang Ji Pharma Co., Ltd. romanized | CYHS2600934 | Generic | 2026/04/23 | Not stated by source | CDE |
| Hubei Guang Ji Pharma Co., Ltd. romanized | CYHS2600933 | Generic | 2026/04/23 | Not stated by source | CDE |
| Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2600601 | Generic | 2026/03/02 | Not stated by source | CDE |
| Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2600600 | Generic | 2026/03/02 | Not stated by source | CDE |
| Shanghai Heng Shan Pharma Co., Ltd. romanized | CYHS2600365 | Generic | 2026/02/04 | Not stated by source | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | CYHS2600330 | Generic | 2026/01/31 | Not stated by source | CDE |
| Shandong Nuo He Kang Pharma Co., Ltd. romanized | CYHS2600265 | Generic | 2026/01/23 | Not stated by source | CDE |
| Shandong Nuo He Kang Pharma Co., Ltd. romanized | CYHS2600264 | Generic | 2026/01/23 | Not stated by source | CDE |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized; Liaoning Kang Bo Shi Pharmaceutical Co., Ltd. romanized | CYHS2600220 | Generic | 2026/01/20 | Not stated by source | CDE |
| Hua Tai Min Kang (Shenyang) Technology Co., Ltd. romanized; Liaoning Kang Bo Shi Pharmaceutical Co., Ltd. romanized | CYHS2600219 | Generic | 2026/01/20 | Not stated by source | CDE |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | CYHS2600211 | Generic | 2026/01/17 | Not stated by source | CDE |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | CYHS2600210 | Generic | 2026/01/17 | Not stated by source | CDE |
| Shandong Cheng Chuang Lan Hai Pharmaceuticals Technology Co., Ltd. romanized; Yuan Da Sheng Ming Ke Xue (Shandong) Co., Ltd. romanized | CYHS2600090 | Generic | 2026/01/08 | Not stated by source | CDE |
| Shandong Cheng Chuang Lan Hai Pharmaceuticals Technology Co., Ltd. romanized; Yuan Da Sheng Ming Ke Xue (Shandong) Co., Ltd. romanized | CYHS2600089 | Generic | 2026/01/08 | Not stated by source | CDE |
| Jiangxi Pharmaceutical Co., Ltd. romanized | CYHS2602580 | Generic | 2026/10/21 | Not stated by source | CDE |
| Jiangxi Pharmaceutical Co., Ltd. romanized | CYHS2602579 | Generic | 2026/10/21 | Not stated by source | CDE |
API registrations
Non-component matches: 40 companies with A status and 13 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 达格列净 · No verified English name | Topfond Pharmaceutical Co., Ltd. | Y20260000662 | I | Exact ingredient | 2026/08/17 | CDE |
| 达格列净 · No verified English name | Jiangsu A Er Fa Group Fu Rui Pharma (Su Qian) Co., Ltd. romanized | Y20260000249 | I | Exact ingredient | 2026/04/10 | CDE |
| 达格列净 · No verified English name | Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | Y20260000255 | I | Exact ingredient | 2026/04/09 | CDE |
| 达格列净 · No verified English name | Hunan Xian Shi Pharmaceutical Co., Ltd. romanized | Y20250001499 | I | Exact ingredient | 2026/01/13 | CDE |
| 达格列净 · No verified English name | Wu Xue Hong Yuan Pharma Co., Ltd. romanized | Y20250001044 | I | Exact ingredient | 2025/12/09 | CDE |
| 达格列净 · No verified English name | Changchun Hai Yue Pharma Co., Ltd. romanized | Y20250000937 | I | Exact ingredient | 2025/09/04 | CDE |
| 达格列净 · No verified English name | Zhejiang Jiang Bei Nan Hai Pharma Co., Ltd. romanized | Y20250000379 | A | Exact ingredient | 2026/10/16 | CDE |
| 达格列净 · No verified English name | Chongqing Kai Lin Pharmaceutical Co., Ltd. romanized | Y20240001191 | A | Exact ingredient | 2026/05/12 | CDE |
| 达格列净 · No verified English name | Beijing Sai Er Bio Pharma Co., Ltd. romanized | Y20240001369 | A | Exact ingredient | 2026/04/21 | CDE |
| 达格列净 · No verified English name | Di Jia Pharma Group Co., Ltd. romanized | Y20240001043 | A | Exact ingredient | 2026/07/20 | CDE |
| 达格列净 · No verified English name | Honour Lab Limited Unit Iii | Y20240000587 | A | Exact ingredient | 2026/10/05 | CDE |
| 达格列净 · No verified English name | Shandong Cheng Hui Shuang Da Pharma Co., Ltd. romanized | Y20240000916 | A | Exact ingredient | 2026/10/17 | CDE |
| 达格列净 · No verified English name | Zhejiang Hong Yuan Pharma Co., Ltd. romanized | Y20240000845 | A | Exact ingredient | 2026/05/20 | CDE |
| 达格列净 · No verified English name | Wan Yang Heng Shui Pharmaceutical Co., Ltd. romanized | Y20240000873 | A | Exact ingredient | 2026/01/05 | CDE |
| 达格列净 · No verified English name | Zhejiang Ao Xiang Pharma Co., Ltd. romanized | Y20240000835 | A | Exact ingredient | 2025/12/29 | CDE |
| 达格列净 · No verified English name | Hubei Tian Shu Pharma Co., Ltd. romanized | Y20240000848 | A | Exact ingredient | 2026/10/27 | CDE |
| 达格列净 · No verified English name | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20240000545 | A | Exact ingredient | 2026/09/05 | CDE |
| 达格列净 · No verified English name | Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | Y20240000242 | A | Exact ingredient | 2025/09/04 | CDE |
| 达格列净 · No verified English name | Zhejiang Jiu Zhou Pharma Co., Ltd. romanized | Y20240000151 | A | Exact ingredient | 2025/10/17 | CDE |
| 达格列净 · No verified English name | Suzhou Zheng Ji Pharma Co., Ltd. romanized | Y20230000874 | A | Exact ingredient | 2026/03/27 | CDE |
| 达格列净 · No verified English name | Beijing Foyou Pharma CO.,LTD | Y20230000752 | A | Exact ingredient | 2024/12/13 | CDE |
| 达格列净 · No verified English name | Jiangsu Deyuan Pharmaceutical Co.,Ltd. | Y20230000695 | A | Exact ingredient | 2025/03/08 | CDE |
| 达格列净 · No verified English name | KRKA, d.d., Novo mesto | Y20230000350 | A | Exact ingredient | 2025/08/06 | CDE |
| 达格列净 · No verified English name | Zhi En Bio Technology Co., Ltd. romanized | Y20230000618 | A | Exact ingredient | 2026/06/04 | CDE |
| 达格列净 · No verified English name | Bai Yin Jing Yu Xin Pharma Co., Ltd. romanized | Y20230000626 | A | Exact ingredient | 2026/04/03 | CDE |
| 达格列净 · No verified English name | MSN Laboratories Private Limited | Y20230000345 | A | Exact ingredient | 2025/07/28 | CDE |
| 达格列净 · No verified English name | Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20230000318 | A | Exact ingredient | 2026/06/09 | CDE |
| 达格列净 · No verified English name | Wei Fang Shi Hai Xin Pharma Co., Ltd. romanized | Y20230000410 | A | Exact ingredient | 2024/09/05 | CDE |
| 达格列净 · No verified English name | Han Rui Pharma (Jing Men) Co., Ltd. romanized | Y20230000355 | A | Exact ingredient | 2024/11/12 | CDE |
| 达格列净 · No verified English name | Cheng Da Pharma Co., Ltd. romanized | Y20230000033 | A | Exact ingredient | 2025/10/27 | CDE |
| 达格列净 · No verified English name | Zhejiang Tian Yu Pharma Co., Ltd. romanized | Y20220001121 | A | Exact ingredient | 2025/04/11 | CDE |
| 达格列净 · No verified English name | Biocon Limited | Y20220000163 | A | Exact ingredient | 2025/09/05 | CDE |
| 达格列净 · No verified English name | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20220000893 | A | Exact ingredient | 2025/12/18 | CDE |
| 达格列净 · No verified English name | Xuan Cheng Mei Nuo Hua Pharma Co., Ltd. romanized | Y20220000754 | A | Exact ingredient | 2024/05/30 | CDE |
| 达格列净 · No verified English name | Fu Xin Long Rui Pharma Co., Ltd. romanized | Y20220000604 | A | Exact ingredient | 2025/05/14 | CDE |
| 达格列净 · No verified English name | Hebei Guo Long Pharmaceutical Co., Ltd. romanized | Y20220000818 | A | Exact ingredient | 2025/12/31 | CDE |
| 达格列净 · No verified English name | Jiangsu Hui Ju Pharma Co., Ltd. romanized | Y20220000848 | A | Exact ingredient | 2024/05/31 | CDE |
| 达格列净 · No verified English name | CSPC OUYI PHARMACEUTICAL CO., LTD. | Y20220000867 | A | Exact ingredient | 2025/10/23 | CDE |
| 达格列净 · No verified English name | MSN Laboratories Private Limited | Y20220000610 | I | Exact ingredient | 2023/11/03 | CDE |
| 达格列净 · No verified English name | CSPC OUYI PHARMACEUTICAL CO., LTD. | Y20220000658 | I | Exact ingredient | 2022/08/22 | CDE |
| 达格列净 · No verified English name | Dr.Reddy's Laboratories Ltd. | Y20220000123 | A | Exact ingredient | 2025/01/11 | CDE |
| 达格列净 · No verified English name | Jiangsu Hui Ju Pharma Co., Ltd. romanized | Y20220000259 | A | Exact ingredient | 2025/07/02 | CDE |
| 达格列净 · No verified English name | Cheng Da Pharma Co., Ltd. romanized | Y20220000029 | I | Exact ingredient | 2023/05/22 | CDE |
| 达格列净 · No verified English name | Sichuan Gowell Pharmaceutical Co., Ltd. | Y20210000979 | A | Exact ingredient | 2023/06/07 | CDE |
| 达格列净 · No verified English name | Jiangsu Pu Run Biopharmaceuticals Co., Ltd. romanized | Y20210001011 | A | Exact ingredient | 2024/03/21 | CDE |
| 达格列净 · No verified English name | AstraZeneca AB | Y20210000736 | A | Exact ingredient | 2026/05/20 | CDE |
| 达格列净 · No verified English name | Morepen Laboratories Ltd | Y20210000321 | I | Exact ingredient | 2021/07/30 | CDE |
| 达格列净 · No verified English name | Honour Lab Limited, Unit - III romanized | Y20210000221 | I | Exact ingredient | 2024/02/27 | CDE |
| 达格列净 · No verified English name | Jiangsu Hao Sen Pharma Group Co., Ltd. romanized | Y20210000556 | A | Exact ingredient | 2023/06/29 | CDE |
| 达格列净 · No verified English name | AstraZeneca AB | Y20210000271 | A | Exact ingredient | 2026/08/21 | CDE |
| 达格列净 · No verified English name | Dr. Reddy's Laboratories Ltd. | Y20210000100 | A | Exact ingredient | 2026/11/08 | CDE |
| 达格列净 · No verified English name | Xin Xiang Shuang Lu Pharma Co., Ltd. romanized | Y20200001479 | A | Exact ingredient | 2023/05/06 | CDE |
| 达格列净 · No verified English name | ZCL Chemicals Limited | Y20200000919 | I | Exact ingredient | 2023/03/24 | CDE |
| 达格列净 · No verified English name | Honour Lab Limited, Unit-III | Y20200000244 | A | Exact ingredient | 2024/01/31 | CDE |
| 达格列净 · No verified English name | Beijing Foyou Pharma CO.,LTD | Y20200000298 | A | Exact ingredient | 2026/05/15 | CDE |
| 达格列净 · No verified English name | Shandong Lukang Pharmaceutical Co.,Ltd. | Y20190000428 | A | Exact ingredient | 2026/07/24 | CDE |
| 达格列净 · No verified English name | Anhui Sen Ji Pharmaceutical Co., Ltd. romanized | Y20260000911 | I | Exact ingredient | 2026/11/02 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/11Accepted
Shandong Li Nuo Pharmaceutical Co., Ltd. romanized; Chongqing Bo Teng Pharma Co., Ltd. romanized
CYHB2602047
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ -
2026/11/11Accepted
Shandong Li Nuo Pharmaceutical Co., Ltd. romanized; Chongqing Bo Teng Pharma Co., Ltd. romanized
CYHB2602046
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ -
2026/11/02Trial registration
Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized
CTR20264055
First-publication date: 2026/11/02 · Site observation date: 2026/11/08
Read by this site on 2026/11/08 as “Ongoing”
Registry classification: Bioequivalence / bioavailability study · Registry phase: Other · See source
Historical registration backfill; not a current-period new event.
View source ↗ -
2026/10/30Trial registration
Guo Da (Jilin) Pharmaceutical Group Co., Ltd. romanized
CTR20263885
First-publication date: 2026/10/30 · Site observation date: 2026/11/08
Read by this site on 2026/11/08 as “Completed”
Registry classification: Bioequivalence / bioavailability study · Registry phase: Other · See source
Historical registration backfill; not a current-period new event.
View source ↗ -
2026/10/30No longer listed under review
Shaanxi Jun Ke Li Pharmaceuticals Technology Co., Ltd. romanized; Anhui Jia He Pharma Co., Ltd. romanized
CYHS2501890
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/05/28
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/30No longer listed under review
Shaanxi Jun Ke Li Pharmaceuticals Technology Co., Ltd. romanized; Anhui Jia He Pharma Co., Ltd. romanized
CYHS2501889
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/05/28
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/21Accepted
Jiangxi Pharmaceutical Co., Ltd. romanized
CYHS2602580
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ -
2026/10/21Accepted
Jiangxi Pharmaceutical Co., Ltd. romanized
CYHS2602579
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ -
2026/10/20Marketing application approved
Chongqing Bo Teng Pharma Co., Ltd. romanized
CYHS2502776 · 国药准字H20266336
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 95 ↗ -
2026/10/20Marketing application approved
Chongqing Bo Teng Pharma Co., Ltd. romanized
CYHS2502775 · 国药准字H20266335
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 94 ↗ -
2026/10/20Marketing application approved
Suzhou Di Yi Pharmaceutical Co., Ltd. romanized
CYHS2501382 · 国药准字H20266380
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 51 ↗ -
2026/10/20Marketing application approved
Suzhou Di Yi Pharmaceutical Co., Ltd. romanized
CYHS2501380 · 国药准字H20266379
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 50 ↗ -
2026/10/15Accepted
Hunan Jiudian Pharmaceutical Co., Ltd
CYHB2601896
Fact date: 2026/10/15 · Site observation date: 2026/10/21
View source ↗ -
2026/10/14Accepted
Jiangxi Shimei Pharmaceutical Co., Ltd
CYHS2602530
Fact date: 2026/10/14 · Site observation date: 2026/10/21
View source ↗ -
2026/10/14Accepted
Jiangxi Shimei Pharmaceutical Co., Ltd
CYHS2602529
Fact date: 2026/10/14 · Site observation date: 2026/10/21
View source ↗ -
2026/09/28Trial registration
Shanxi Qian Hui Pharma Co., Ltd. romanized
CTR20263628
First-publication date: 2026/09/28 · Site observation date: 2026/11/08
Read by this site on 2026/11/08 as “Ongoing”
Registry classification: Bioequivalence / bioavailability study · Registry phase: Other · See source
Historical registration backfill; not a current-period new event.
View source ↗ -
2026/09/22Accepted
Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Yan Tai Dong Cheng Da Yang Pharmaceutical Co., Ltd. romanized
CYHS2602379
Fact date: 2026/09/22 · Site observation date: 2026/10/21
View source ↗ -
2026/09/22Accepted
Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Yan Tai Dong Cheng Da Yang Pharmaceutical Co., Ltd. romanized
CYHS2602378
Fact date: 2026/09/22 · Site observation date: 2026/10/21
View source ↗ -
2026/09/16Accepted
Zhao Yang Long Cheng Pharmaceutical Co., Ltd. romanized
CYHS2602295
Fact date: 2026/09/16 · Site observation date: 2026/10/21
View source ↗ -
2026/09/16Accepted
Zhao Yang Long Cheng Pharmaceutical Co., Ltd. romanized
CYHS2602294
Fact date: 2026/09/16 · Site observation date: 2026/10/21
View source ↗ -
2026/09/03Accepted
Shandong Lukang Pharmaceutical Co.,Ltd.
CYHB2601679
Fact date: 2026/09/03 · Site observation date: 2026/10/21
View source ↗ -
2026/09/03Accepted
Shandong Lukang Pharmaceutical Co.,Ltd.
CYHB2601678
Fact date: 2026/09/03 · Site observation date: 2026/10/21
View source ↗ -
2026/08/28Accepted
Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized
CYHS2602153
Fact date: 2026/08/28 · Site observation date: 2026/10/21
View source ↗ -
2026/08/28Accepted
Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized
CYHS2602152
Fact date: 2026/08/28 · Site observation date: 2026/10/21
View source ↗ -
2026/08/26Accepted
Tai Kang Hai En Pharma Co., Ltd. romanized
CYHS2602126
Fact date: 2026/08/26 · Site observation date: 2026/10/21
View source ↗ -
2026/08/26Accepted
Tai Kang Hai En Pharma Co., Ltd. romanized
CYHS2602125
Fact date: 2026/08/26 · Site observation date: 2026/10/21
View source ↗ -
2026/08/20Trial registration
Chongqing Xi Er An Pharma Co., Ltd. romanized
CTR20263229
First-publication date: 2026/08/20 · Site observation date: 2026/11/08
Read by this site on 2026/11/08 as “Ongoing”
Registry classification: Bioequivalence / bioavailability study · Registry phase: Other · See source
Historical registration backfill; not a current-period new event.
View source ↗ -
2026/08/19Trial registration
Liao Cheng Gao Xin Bio Technology Co., Ltd. romanized
CTR20263124
First-publication date: 2026/08/19 · Site observation date: 2026/11/08
Read by this site on 2026/11/08 as “Ongoing”
Registry classification: Bioequivalence / bioavailability study · Registry phase: Other · See source
Historical registration backfill; not a current-period new event.
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Dapagliflozin Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy